Cutaneous amebiasis is a skin infection caused by the protozoan parasite Entamoeba histolytica. It typically arises from intestinal amebiasis, leading to skin lesions, ulcers, and secondary bacterial infections. Accurate coding with ICD-10 Code A06.7 is essential for proper diagnosis, documentation, and billing, facilitating effective public health reporting and resource allocation.
What is ICD-10 Code A06.7 for Cutaneous amebiasis?
ICD-10 Code A06.7 represents Cutaneous amebiasis, a condition characterized by skin lesions resulting from the invasion of Entamoeba histolytica. This code should be used in clinical documentation when a patient presents with skin manifestations linked to amebic infection, ensuring accurate billing and tracking of this infectious disease.
ICD-10 Code A06.7 – Clinical Definition and Explanation of Cutaneous amebiasis
Cutaneous amebiasis is primarily caused by the spread of Entamoeba histolytica from the intestines to the skin, often occurring in immunocompromised individuals. The condition can lead to significant morbidity and requires prompt medical intervention to prevent complications.
Key Clinical Features:
- Presence of painful skin lesions or ulcers
- Possible secondary bacterial infections
- History of gastrointestinal amebiasis
- Immunocompromised status of the patient
ICD-10 Code A06.7 for Cutaneous amebiasis – SOAP Notes & Clinical Use
In SOAP notes, ICD-10 Code A06.7 is utilized to document the patient's symptoms, assessment findings, and treatment plans related to Cutaneous amebiasis. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.
What Does ICD-10 Code A06.7 for Cutaneous amebiasis Mean in SOAP Notes?
ICD-10 Code A06.7 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Cutaneous amebiasis. This linkage is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Treatment Options for ICD-10 Code A06.7 – Cutaneous amebiasis
Cutaneous amebiasis may necessitate hospitalization, especially in severe cases. Treatment typically involves antiparasitic medications and supportive care.
Antibiotic Therapy:
- Metronidazole (750 mg TID for 7-10 days)
- Tinidazole (2 g once daily for 3 days)
- Alternative: Iodoquinol (650 mg TID for 20 days)
Supportive Care:
- Wound care for skin lesions
- Pain management
- Hydration and nutritional support
Infection Control:
- Strict hand hygiene practices
- Isolation precautions if necessary
- Education on preventing transmission
How to Document Symptoms of Cutaneous amebiasis (ICD-10 A06.7) in SOAP Notes
Subjective:
- Patient reports painful skin lesions
- History of recent gastrointestinal symptoms
- Complaints of itching and discomfort
- No known allergies reported
Objective:
- Erythematous lesions observed on examination
- Presence of ulceration with exudate
- Vital signs stable
- No fever noted
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Cutaneous amebiasis (ICD-10 Code A06.7)
Assessment:
- Diagnosis: Cutaneous amebiasis, moderate severity
- ICD-10 Code: A06.7
- Contributing factors: Recent travel to endemic areas
- Possible immunocompromised state
Plan:
- Initiate metronidazole therapy
- Educate patient on wound care
- Schedule follow-up in one week
- Monitor for signs of secondary infection
Treatment & Plan Section for ICD-10 Code A06.7 – Cutaneous amebiasis
- First-line pharmacologic treatment: Metronidazole
- Non-pharmacologic strategies: Proper wound care and hygiene
- Monitoring: Regular assessment of skin lesions
- Follow-up practices: Weekly check-ups until resolution
Using ICD-10 Code A06.7 for Cutaneous amebiasis in Billing & SOAP Note Compliance
- Select appropriate ICD-10 code based on clinical findings
- Document symptoms clearly in Subjective (S) and Objective (O) sections
- Ensure treatment plans align with clinical guidelines
- Include relevant CPT codes for services rendered
Related ICD-10 Codes Often Used with Cutaneous amebiasis
- A06.0 – Amoebic dysentery
- A06.1 – Amoebic liver abscess
- B60.9 – Amebiasis, unspecified
- B65.9 – Amebic infection, unspecified
ICD-10 Code A06.7 in Medical Billing and Insurance for Cutaneous amebiasis
ICD-10 Code A06.7 is critical for billing in hospital, ER, or infectious disease care settings.
Billing Notes:
- Document all relevant patient history and symptoms
- Use the code in conjunction with appropriate CPT codes
- Ensure clarity in documentation to support claims
- Review coding guidelines for compliance
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, level 3 |
| 36415 | Collection of venous blood by venipuncture |
| 87070 | Culture, bacterial, any source, except urine |
Frequently Asked Questions
Common Questions About Using ICD-10 Code A06.7 for Cutaneous amebiasis
What are the common symptoms of Cutaneous amebiasis?
Common symptoms include painful skin lesions, ulceration, and possible secondary infections. Patients may also report itching and discomfort in the affected areas.
How is Cutaneous amebiasis diagnosed?
Diagnosis is typically made through clinical evaluation of skin lesions, patient history of gastrointestinal symptoms, and laboratory tests confirming Entamoeba histolytica infection.
Is Cutaneous amebiasis contagious?
Cutaneous amebiasis itself is not directly contagious; however, the underlying Entamoeba histolytica can spread through fecal-oral transmission, necessitating good hygiene practices.
What is the treatment for Cutaneous amebiasis?
Treatment usually involves antiparasitic medications such as metronidazole, along with supportive care for skin lesions and monitoring for secondary infections.
